Source: Annual Congress 2008 - Should we change our attention to respiratory diseases because of climate change?



Rating:

Share or cite this content

Citations should be made in the following way:
J. Ayres (Aberdeen, United Kingdom). Recommendations. Annual Congress 2008 - Should we change our attention to respiratory diseases because of climate change?

Member's Comments

No comment yet.

Related content which might interest you: Recommendations for specific diagnostic interventions Source: International Congress 2018 – Idiopathic pulmonary fibrosis diagnosis: new guidelines Year: 2018 A Guide to Guidelines for Professional Societies and Other Developers of Recommendations Source: Guideline 2012 Year: 2012 Comparison of COPD Management Practices with Expert Recommendations among Pulmonologists and Primary Care Providers Source: International Congress 2018 – Medical education via the web and the internet Year: 2018 Producing evidence-based guidelines for NICE Source: International Congress 2014 – Developing evidence-based guidelines for ERS: theory, practicalities and challenges Year: 2014 Treatment options and recommendations Source: International Congress 2019 – European guidelines for malignant pleural mesothelioma management in 2019 Year: 2019 Treatment options and recommendations Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis Year: 2021 Treatment options and recommendations Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis Year: 2021 Treatment options and recommendations Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea Year: 2021 Rethinking the guidelines after COVID-19 Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era Year: 2021 International Recommendations for  HAP and VAP Source: International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP) Year: 2017 Severe Asthma, Current Options and Limitations of Pharmacotherapy Source: Research Seminar 2007 - Severe Asthma Year: 2007 Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1277-1278 Year: 2012 Disseminating and implementing guidelines Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1278-1279 Year: 2012 The WHO Guidelines for the Programmatic Management of drug-resistant TB: the 2011 update - recommendations and evidence Source: Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project) Year: 2011 Latest updates in the guidelines of asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Methodology of ERS guidelines development Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012